Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction.

Zahra LotfollahiAna P Q MelloFrancisco Antônio Helfenstein FonsecaLuciene O MachadoAndressa F MathiasMaria Cristina de Oliveira IzarNagila R T DamascenoCristiano L P OliveiraAntônio Martins Figueiredo Neto

Published in: PloS one (2022)

The quality of LDL particles was influenced by the antiplatelet/lipid-lowering strategy, with ticagrelor being associated with the best performance with both lipid-lowering therapies. Trial registration: NCT02428374.

Keyphrases

acute myocardial infarction
percutaneous coronary intervention
fatty acid
clinical trial
study protocol
left ventricular
randomized controlled trial
st segment elevation myocardial infarction
heart failure
antiplatelet therapy
st elevation myocardial infarction
phase ii
open label